Author:
Regules Jason A.,Cicatelli Susan B.,Bennett Jason W.,Paolino Kristopher M.,Twomey Patrick S.,Moon James E.,Kathcart April K.,Hauns Kevin D.,Komisar Jack L.,Qabar Aziz N.,Davidson Silas A.,Dutta Sheetij,Griffith Matthew E.,Magee Charles D.,Wojnarski Mariusz,Livezey Jeffrey R.,Kress Adrian T.,Waterman Paige E.,Jongert Erik,Wille-Reece Ulrike,Volkmuth Wayne,Emerling Daniel,Robinson William H.,Lievens Marc,Morelle Danielle,Lee Cynthia K.,Yassin-Rajkumar Bebi,Weltzin Richard,Cohen Joe,Paris Robert M.,Waters Norman C.,Birkett Ashley J.,Kaslow David C.,Ballou W. Ripley,Ockenhouse Christian F.,Vekemans Johan
Funder
GSK Biologicals
PATH Malaria Vaccine Initiative (to GSK Vaccines and the MMRP)
Bill and Melinda Gates Foundation (to the Malaria Vaccine Initiative and Atreca)
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Reference29 articles.
1. WHO world malaria report 2015. http://www.who.int/malaria/publications/world_malaria_report_2015/report/en/ . Accessed 16 December 2015.
2. WHO's 68 World Health Assembly 2015. Malaria: draft global technical strategy. Report A68/28, 2015. http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_28-en.pdf?ua=1. Accessed 21 June 2016.
3. Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects
4. WHO Malaria Vaccine Funders Group. Malaria vaccine technology roadmap, 2013. http://www.who.int/immunization/topics/malaria/vaccine_roadmap/TRM_update_nov13.pdf?ua=1. Accessed 21 June 2016.
5. First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children